Formula Growth’s Insmed INSM Stock Holding History

Formula Growth’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,000	Closed	-$1.47M	–	156
2026 Q1	$1.47M	Buy	+9,000	New	+$1.38M	0.66%	56

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Formula Growth's INSM Position: Q2 2026 in Review

Formula Growth sold out of Insmed (INSM) in Q2 2026, closing a stake of 9,000 shares — an estimated $1.47M sold.

Formula Growth first reported a position in INSM in Q1 2026 and held it in 1 quarter. The position peaked at $1.47M in Q1 2026. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Formula Growth reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
Formula Growth sold 9,000 Insmed shares in Q2 2026, an estimated $1.47M.
Formula Growth first reported a position in Insmed in Q1 2026 and held it in 1 quarter.
Formula Growth's Insmed position peaked at $1.47M in Q1 2026.
665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.